CatalystEU/UK

ROCHE-OWNED CHUGAI PHARMA TO RAMP UP IN-HOUSE OUTPUT WITH 50% CAPEX BOOST - NIKKEI

Chugai's 50% capex boost signals expanded in-house manufacturing capacity.

What changed

Chugai's 50% capex boost signals expanded in-house manufacturing capacity.

Why it matters

Chugai's 50% capex boost signals expanded in-house manufacturing capacity. — impact context not separately stored; see What changed.

Sources